betaxolol has been researched along with Disease Models, Animal in 9 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Péladeau, C | 1 |
| Adam, N | 1 |
| Bronicki, LM | 1 |
| Coriati, A | 1 |
| Thabet, M | 1 |
| Al-Rewashdy, H | 1 |
| Vanstone, J | 1 |
| Mears, A | 1 |
| Renaud, JM | 1 |
| Holcik, M | 1 |
| Jasmin, BJ | 1 |
| Pang, IH | 1 |
| Wang, WH | 1 |
| Clark, AF | 1 |
| Cheon, EW | 1 |
| Park, CH | 1 |
| Kim, YS | 1 |
| Cho, CH | 1 |
| Chung, YC | 1 |
| Kwon, JG | 1 |
| Yoo, JM | 1 |
| Choi, WS | 1 |
| Cho, GJ | 1 |
| Przegaliński, E | 1 |
| Filip, M | 1 |
| Chojnacka-Wójcik, E | 1 |
| Tatarczyńska, E | 1 |
| Morrison, JC | 1 |
| Nylander, KB | 1 |
| Lauer, AK | 1 |
| Cepurna, WO | 1 |
| Johnson, E | 1 |
| Gross, RL | 1 |
| Hensley, SH | 1 |
| Gao, F | 1 |
| Wu, SM | 1 |
| Grehn, F | 1 |
9 other studies available for betaxolol and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Identification of therapeutics that target eEF1A2 and upregulate utrophin A translation in dystrophic muscles.
Topics: 5' Untranslated Regions; Animals; Betaxolol; Cell Line; Disease Models, Animal; Drug Evaluation, Pre | 2020 |
Acute effects of glaucoma medications on rat intraocular pressure.
Topics: Animals; Antihypertensive Agents; Betaxolol; Disease Models, Animal; Dose-Response Relationship, Dru | 2005 |
Protective effects of betaxolol in eyes with kainic acid-induced neuronal death.
Topics: Analysis of Variance; Animals; Betaxolol; Cell Count; Cell Death; Choline O-Acetyltransferase; Disea | 2006 |
The role of 5-hydroxytryptamine1A (5-HT1A) receptors in the anticonflict activity of beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Betaxolol; Conflict, Psychological; Disease Models, A | 1994 |
Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Clonidine; Disease Model | 1998 |
Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of beta-blockers.
Topics: Action Potentials; Adrenergic beta-Antagonists; Ambystoma; Animals; Betaxolol; Calcium Channels; Dis | 1999 |
[Prospects for neuroprotective glaucoma therapy].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Apoptosis; | 2001 |